RESYCA B.V. is a joint venture between Recipharm and Medspray, based in the Netherlands, specializing in soft mist inhalation and nasal spray drug delivery device technology. The company develops and manufactures syringe-based inhaler devices and nasal sprays for liquid formulations, including biologics and mRNA delivery. RESYCA holds MDR certification from TUV SUD and licenses its technology to pharmaceutical partners.
soft mist inhalation technology, pre-filled syringe inhalers, nasal spray drug delivery, device-drug combination products, aerosol technology for biologics
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.